Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies.
Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD. · 2019
Read Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. by Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6469300.txt.
Introduction
Liu and co-authors update the global birth prevalence of congenital heart defects with a meta-analysis of 260 studies covering 130,758,851 live births from 1970 to 2017. Reported rates differ hugely by region, and whether the rise is real or a detection artifact has been disputed.
Prevalence climbed to 9.410 per 1,000 births in 2010-17. Mild lesions, ventricular and atrial septal defects and patent ductus arteriosus, explained 93.4 percent of the increase, pointing at better postnatal detection rather than more disease. Severe outflow obstructions fell, consistent with prenatal detection and termination. Asia reported the highest rate at 9.342 per 1,000 and Africa the lowest at 2.315, a gap the authors read as unmet diagnostic capacity.
Catalog record
| CREATOR | Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies By Yingjuan Liu, Sen Chen, Liesl Zühlke, Graeme C Black, Mun-kit Choy, Ningxiu Li, Bernard D Keavney Published in: International Journal of Epidemiology DOI: 10.1093/ije/dyz009 ABSTRACT Abstract Background Globally, access to healthcare and diagnostic technologies are known to substantially impact the reported birth prevalence of congenital heart disease (CHD). Previous studies have shown marked heterogeneity between different regions, with a suggestion that CHD prevalence is rising globally, but the degree to which this reflects differences due to environmental or genetic risk factors, as opposed to improved detection, is uncertain. We performed an updated systematic review to address these issues. Methods Studies reporting the birth prevalence of CHD between the years 1970–2017 were identified from searches of PubMed, EMBASE, Web of Science and Google Scholar. Data on the prevalence of total CHD and 27 anatomical subtypes of CHD were collected. Data were combined using random-effect models. Subgroup and meta-regression analyses were conducted, focused on geographical regions and levels of national income. Results Two hundred and sixty studies met the inclusion criteria, encompassing 130 758 851 live births. The birth prevalence of CHD from 1970–2017 progressively increased to a maximum in the period 2010–17 of 9.410/1000 [95% CI (confidence interval) 8.602–10.253]. This represented a significant increase over the fifteen prior years (P = 0.031). The change in prevalence of mild CHD lesions (ventricular septal defect, atrial septal defect and patent ductus arteriosus) together explained 93.4% of the increased overall prevalence, consistent with a major role of improved postnatal detection of less severe lesions. In contrast the prevalence of lesions grouped together as left ventricular outflow tract obstruction (which includes hypoplastic left heart syndrome) decreased from 0.689/1000 (95% CI 0.607–0.776) in 1995–99, to 0.475/1000 (95% CI 0.392–0.565; P = 0.004) in 2010–17, which would be consistent with improved prenatal detection and consequent termination of pregnancy when these very severe lesions are discovered. There was marked heterogeneity among geographical regions, with Africa reporting the lowest prevalence [2.315/1000 (95% CI 0.429–5.696)] and Asia the highest [9.342/1000 (95% CI 8.072–10.704)]. Conclusions The reported prevalence of CHD globally continues to increase, with evidence of severe unmet diagnostic need in Africa. The recent prevalence of CHD in Asia for the first time appears higher than in Europe and America, where disease ascertainment is likely to be near-complete, suggesting higher genetic or environmental susceptibility to CHD among Asian people. Keywords: Congenital heart disease, prevalence, meta-analysis, systematic review, geographical region, national income Key MessagesThis meta-analysis incorporated global data on prevalence of congenital heart disease (CHD) from 260 studies (130 758 851 births), of which 142 (103 732 049 births) were published after 2010.The prevalence of ‘mild lesions’ [ventricular septal defect (VSD), atrial septal defect (ASD) and patent ductus arteriosus (PDA)] in particular, increased throughout the study period, probably reflecting improved detection. The prevalence of left ventricular outflow tract obstruction (LVOTO) was decreased since 1995, possibly reflecting increased prenatal diagnosis and consequent termination of pregnancy.Regional differences in CHD prevalence were identified. The average CHD prevalence reported from Africa was the lowest (overall and mild lesions), whereas that from Asia was the highest (mild lesions).The prevalences of ASD (reversely) and LVOTO (positively) were both correlated with gross national incomes (GNIs).Overall, the reported birth prevalence of CHD globally is increasing, raising important questions regarding healthcare resource allocation to care for this complex patient group. INTRODUCTION Congenital heart disease (CHD) is the commonest birth defect worldwide, affecting millions of newborns every year.1 CHD is typically defined as a structural abnormality of the heart and/or great vessels that is present at birth. Although approximately 20% of CHD incidence can be attributed to genetic syndromes, teratogen exposure or maternal diabetes, there remains substantial uncertainty regarding risk factors for the remaining 80% of cases.2 Improved medical and surgical care have transformed the prognosis for children born with severe CHD in developed countries, but in parts of the developing world, access to treatment for the severer conditions remains unavailable. Indeed, the birth prevalence of CHD across the world is not yet accurately established, potentially obscuring differences in environmental and/or genetic risk factors for CHD between regions that could have public health consequences. A systematic review of global prevalence data since 1930 was conducted by van der Linde et al.1 in 2010, suggesting an increase in CHD prevalence from the 1930s until 1995, with stabilization between the years 1995–2009. Marked heterogeneity between global regions was noted, chiefly attributed to differential availability of diagnostic medical technology. However, since that valuable report, the literature has significantly expanded, and the availability of diagnostic technology in some parts of the developing world has likely changed considerably in parallel with rapid economic development, prompting us to conduct an updated systematic review. In addition, the size of the available dataset in 2010 restricted van der Linde et al. to subgroup analysis of only the eight commonest CHD subtypes; we hypothesized that in a larger dataset, subgroup analysis of less common, and typically more severe, phenotypes would be possible to discern important prevalence trends. METHODS Search strategy We searched the literature with a cut-off date of June 2017, using PubMed, EMBASE, Web of Science and Google Scholar, for peer-reviewed studies with English abstracts which reported the birth prevalence of CHD anywhere in the world. The main search terms used were ‘congenital heart disease’, or ‘congenital heart defect’, or ‘heart abnormality’, or ‘heart malformation’, and ‘prevalence’, or ‘incidence’, or ‘frequency’, or ‘epidemiology’. We restricted ourselves to studies published after 1970, as this approximately coincides with the widespread adoption of echocardiography, the current standard diagnostic modality in paediatric cardiology.3 Data review Review for eligibility was carried out in three stages, of titles, abstracts and full texts. All review and data extraction was carried out independently by the same two authors (Y.L. and S.C.) and any discrepancy resolved by discussion. In short, original peer-reviewed studies reporting on overall CHD prevalence of populations between birth and age 6 years were included. Studies on specific populations which would cause bias in estimation, for example the children of women with diabetes, were excluded. The details of inclusion and exclusion criteria are shown in Supplementary Table 1, available as Supplementary data at IJE online. All included papers were evaluated with the Newcastle–Ottawa Scale (NOS, maximum 9 stars), which is a quality assessment tool recommended by Cochrane Collaboration and widely used for observational studies.4–6 Quality scores and list of included papers are presented in ‘Supplementary Data’, available as Supplementary data at IJE online. Data on overall CHD prevalence, and prevalence of 27 CHD subtypes, were extracted (raw data and abbreviations of CHD subtypes are available in ‘Supplementary Data, available as Supplementary data at IJE online). In the principal analyses, CHD was classified into seven phenotypic categories, following the approach of Botto et al.7 which groups together lesions on the basis of their anatomical/developmental similarity (Supplementary Table 2, available as Supplementary data at IJE online). With respect to assigning lesion severity, we followed the modified classification of Hoffmann8–10 (Supplementary Table 3, available as Supplementary data at IJE online); ventricular septal defect (VSD), atrial septal defect (ASD) and patent ductus arteriosus (PDA) were grouped together as ‘mild’ lesions. For time-trend